Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC XST-14 | 2607143-50-8 | 99.3% | 291.34 | 50 MG
SDP

Catalog No. 5000350445
Encompass_Preferred

XST-14 is a potent, competitive, and highly selective ULK1 inhibitor with an IC50 of 26.6 nM. It induces autophagy inhibition by reducing the phosphorylation of the ULK1 downstream substrate. XST-14 also induces apoptosis in hepatocellular carcinoma (HCC) cells and exhibits antitumor effects.

  • Potent, competitive, and highly selective ULK1 inhibitor
  • Induces autophagy inhibition
  • Reduces phosphorylation of ULK1 downstream substrate
  • Induces apoptosis in hepatocellular carcinoma (HCC) cells
  • Exhibits antitumor effects

Catalog No. 50-003-50445 Supplier Medchemexpress LLC Supplier No. HY13750650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

XST-14 is a potent, competitive, and highly selective ULK1 inhibitor with an IC50 of 26.6 nM. It induces autophagy inhibition by reducing the phosphorylation of the ULK1 downstream substrate. XST-14 also induces apoptosis in hepatocellular carcinoma (HCC) cells and exhibits antitumor effects.

  • Potent, competitive, and highly selective ULK1 inhibitor
  • Induces autophagy inhibition
  • Reduces phosphorylation of ULK1 downstream substrate
  • Induces apoptosis in hepatocellular carcinoma (HCC) cells
  • Exhibits antitumor effects

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.